This site is intended for health professionals only
Sunday 16 June 2019
LatestNews
Share |

Latest News

Tildrakizumab shows promising efficacy and safety in psoriatic arthritis

Friday 14th June 2019
The results of a Phase IIB study presented at EULAR 2019 demonstrate superior efficacy and comparable safety of tildrakizumab versus placebo in patients with psoriatic arthritis.1
 
By week 24 in the study, a significantly higher proportion of patients receiving tildrakizumab (at any dose) achieved a 90% reduction in Psoriasis Area and Severity Index (PASI 90), and a 50% reduction in American College of Rheumatology response...
Thu, 6 Jun 2019
The risk of pneumonia was highest among those using strong opioids, such as oxycodone or fentanyl, but the risk was also increased among those using buprenorphine, tramadol or codeine
Thu, 6 Jun 2019
In the Phase III POLYP 1 and POLYP 2 studies, omalizumab met both co-primary endpoints and key secondary endpoints in adults with chronic rhinosinusitis with nasal polyps with inadequate response to intranasal corticosteroids
Thu, 6 Jun 2019
The results support a robust set of existing data demonstrating the sustained efficacy, safety, and tolerability of continuous ibrutinib treatment in patients with CLL
Thu, 6 Jun 2019
Pancreatic Cancer Action is launching its first multi-targeted awareness initiative awareness amongst the general public, pharmacy teams and GPs to ensure as many people are aware of pancreatic cancer as possible
Thu, 30 May 2019
QUARTZ is the first completed study of the Phase III PLATINUM clinical development program which evaluates both QMF149 and QVM149 (indacaterol acetate, glycopyrronium bromide and mometasone furoate)
Wed, 29 May 2019
The PHARM-CHF trial investigated whether regularly seeing a pharmacist improves adherence to heart failure medications
Thu, 23 May 2019
Inotersen is the world’s first and only subcutaneous RNA-targeting drug designed to reduce the production of human transthyretin protein

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine